Docetaxel
FDA Approved: * March 8, 2011Pharm Company: * HOSPIRA INC
Category: Cancer
Docetaxel (DTX or DXL), sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer.[4] This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer.[5] It may be used by itself or along with other chemotherapy medication.[4] It is given by slow injection into a vein.[4] Common side effects include hair loss, cytopenia... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Docetaxel 20 mg/2ml Intravenous Injection, Solution, Concentrate
NDC: 0069-9141
Labeler:
Pfizer Laboratories Div Pfizer Inc
Docetaxel 80 mg/8ml Intravenous Injection, Solution, Concentrate
NDC: 0069-9142
Labeler:
Pfizer Laboratories Div Pfizer Inc
Docetaxel 200 mg/20ml Intravenous Injection, Solution, Concentrate
NDC: 0069-9144
Labeler:
Pfizer Laboratories Div Pfizer Inc
Docetaxel 20 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0143-9204
Labeler:
Hikma Pharmaceuticals USA Inc.
Docetaxel 20 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0143-9205
Labeler:
Hikma Pharmaceuticals USA Inc.
